Agilent | A - Equity Capital And Reserves


Agilent reported $6.74B in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Abbott USD 52.13B 1.3B Dec/2025
Agilent USD 6.74B 371M Sep/2025
Align Technology USD 3.96B 44.68M Sep/2025
Bio Techne USD 2.01B 45.18M Dec/2025
Bio-Rad Laboratories USD 7.45B 716.8M Dec/2025
Bruker USD 2.49B 625.6M Sep/2025
Charles River Laboratories USD 3.16B 240.82M Dec/2025
Danaher USD 52.53B 1.46B Dec/2025
Dentsply International USD 1.48B 482M Sep/2025
Edwards Lifesciences USD 10.2B 340.3M Sep/2025
Exact Sciences USD 2.4B 100.37M Dec/2025
Henry Schein USD 3.24B 116M Dec/2025
Hologic USD 5.25B 197.2M Dec/2025
Illumina USD 2.72B 342M Dec/2025
Intuitive Surgical USD 17.82B 894.3M Dec/2025
IQVIA Holdings USD 6.5B 343M Dec/2025
Laboratory Of America USD 8.62B 93.2M Dec/2025
Mettler Toledo International USD -23.64M 225.56M Dec/2025
Myriad Genetics USD 372.8M 15.3M Sep/2025
OraSure Technologies USD 361.98M 18.74M Sep/2025
Quest Diagnostics USD 7.17B 88M Dec/2025
Quidel USD 1.92B 115.9M Dec/2025
Repligen USD 2.11B 1.66B Dec/2025
Revvity USD 7.38B 180.27M Sep/2025
Roche Holding CHF 33.8B 758M Dec/2025
Thermo Fisher Scientific USD 53.54B 2.38B Dec/2025
Waters USD 2.56B 230.55M Dec/2025
Zimmer Biomet Holdings USD 12.7B 68.3M Dec/2025